000			05757nam a22003495i 4500
001			314715
003			MX-SnUAN
005			20160429160806.0
007			cr nn 008mamaa
008			160108s2014 xxk| s |||| 0|eng d
020			_a9781447164043 _9978-1-4471-6404-3
035			_avtls000414585
039		9	_y201601081053 _zstaff
050		4	_aRD535.7-539.5
245	1	0	_aDifficult decisions in thoracic surgery : _ban evidence-based approach / _cedited by Mark K. Ferguson.
250			_a3rd ed. 2014.
264		1	_aLondon : _bSpringer London : _bSpringer, _c2014.
300			_axxi, 787 páginas : _b18 ilustraciones, 10 ilustraciones en color.
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
490	0		_aDifficult Decisions in Surgery: An Evidence-Based Approach, _x2198-7750 ; _v1
500			_aSpringer eBooks
505	0		_a1. Introduction -- Part 1. Evaluations and Decisions -- 2. Evidence based medicine: quality of evidence and evaluation systems -- 3. Decision analytic techniques and other decision processes -- 4. Decision making: the surgeon's perspective -- 5. Decision making: the patient's perspective -- Part 2. Lung.- 6. Indications for pretreatment pathologic mediastinal staging in Non-small Cell Lung Cancer (NSCLC) -- 7. Preoperative Smoking Cessation for Lung Resection Patients -- 8. High tech exercise testing in assessing candidates for lung resection -- 9. Management of perioperative anticoagulation during lung resection -- 10. Perioperative arrhythmia prophylaxis for major lung resection -- 11. VATS vs open lobectomy for stage I or II NSCLC -- 12. Robotic-assisted thoracoscopic surgery (RATS) versus video-assisted thoracoscopic surgery (VATS) lobectomy for Stage I or II non-small cell lung cancer (NSCLC) -- 13. Lobectomy after induction therapy for non-small cell lung cancer  in the presence of persistent N2 disease -- 14. Pneumonectomy after induction therapy for non-small cell lung cancer -- 15. Resection vs SBRT for stage I NSCLC in patients with good pulmonary function -- 16. Digital drainage systems after major lung resection -- 17. Management of Persistent Post-operative Alveolar Air Leak -- 18. Surveillance after resection of stage I non small cell lung cancer -- 19. Support therapy for lung failure: The utility of device therapy -- 20. Extracorporeal support for lung grafts prior to transplantation -- 21. Pulmonary Metastasectomy -- Part 3. Esophagus -- 22. Optimal therapy for Barrett High Grade Dysplasia -- 23. Preoperative chemo versus chemoradiotherapy for regionally advanced esophageal adenocarcinoma -- 24. The role of surgery in the management of regionally advanced esophageal squamous cell cancer -- 25. Optimal surgical approach to esophagectomy for distal esophageal adenocarcinoma -- 26. Regional extent of lymphadenectomy for esophageal cancer -- 27. Optimal number of lymph nodes to resect for esophageal cancer -- 28. Salvage esophagectomy for persistent disease after definitive chemoradiotherapy -- 29. Gastric emptying procedure after esophagectomy -- 30. Postoperative adjuvant therapy after resection of regionally advanced esophageal cancer -- 31. Prophylactic antireflux surgery in lung transplantation -- 32. Surgical versus Endoscopic Management for esophageal perforations -- 33. Stent for esophageal anastomotic leak -- 34. Management of small esophageal GIST tumors -- 35. Surgery for minimally symptomatic pulsion diverticula of the thoracic esophagus -- 36. Partial versus total fundoplication for GERD in patients with normal esophageal motility -- Part 4. Diaphragm -- 37. Diaphragm pacing for paralysis -- 38. Minimally invasive versus open repair of giant paraesophageal hernia -- 39. Synthetic reinforcement of diaphragm closure for large hiatal hernia repair -- 40. Diaphragmatic plication for eventration -- 41. Management of recurrent minimally symptomatic paraesophageal hernia -- Part 5. Airway -- 42. Stenting for benign airway obstruction -- 43. Bioengineered tissues for tracheal reconstruction -- 44. Percutaneous versus standard tracheostomy in the critically ill adult -- 45. Carinal resection for Non Small Cell Lung Cancer -- Part 6. Pleura and Pleural Spaces -- 46. Management of Persistent Postoperative Air Leaks -- 47. Fibrinolytics for managing pleural empyema -- 48. VATS versus open management of pleural empyema -- 49. Optimal management of symptomatic malignant pleural effusion -- 50. Pleurectomy versus radical pleuropneumonectomy for malignant pleural mesothelioma -- 51. Surgery and medical therapy for malignant pleural mesothelioma -- Part 7. Mediastinum -- 52. Extended versus standard thymectomy for myasthenia gravis -- 53. Optimal approach for resection of encapsulated thymoma: open versus VATS -- 54. Robotic versus VATS thymectomy for encapsulated thymoma -- 55. Video mediastinoscopy versus standard mediastinoscopy -- 56. Debulking for extensive thymoma -- 57. Surgery for palmar hyperhidrosis: patient selection and extent of surgery -- Part 8. Chest Wall -- 58. Synthetic versus biologic reconstruction of bony chest wall defects -- 59. Management of flail chest -- 60. Management of pectus deformities in adults.
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700	1		_aFerguson, Mark K, _eeditor. _9322498
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9781447164036
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4471-6404-3 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c314715 _d314715